Global Cell and Gene Therapy Drug Delivery Devices Market Insights, Forecast to 2028

Cell and gene therapy drug delivery industry is a transformative industry whose full potential is only just beginning to emerge. Cell and gene therapy involves the extraction of cells, protein, or genetic material (DNA) from the donor, and altering them to provide highly personalized therapy. Cell and gene therapies may offer longer-lasting effects than traditional medicines. One of the significant drugs of the cell and gene therapy industry is CAR-T cell-based medicines, which include both cell therapy and gene therapy. Various market players are actively investing in the research and development of the cell and gene therapy industry. The players are offering improved and new products, which meet the critical needs of patients.

Market Analysis and Insights: Global Cell and Gene Therapy Drug Delivery Devices Market

The global Cell and Gene Therapy Drug Delivery Devices market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Sterile Insulin Syringe accounting for % of the Cell and Gene Therapy Drug Delivery Devices global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Luxturna segment is altered to an % CAGR throughout this forecast period.

China Cell and Gene Therapy Drug Delivery Devices market size is valued at US$ million in 2021, while the North America and Europe Cell and Gene Therapy Drug Delivery Devices are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Cell and Gene Therapy Drug Delivery Devices landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cell and Gene Therapy Drug Delivery Devices market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cell and Gene Therapy Drug Delivery Devices market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cell and Gene Therapy Drug Delivery Devices market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cell and Gene Therapy Drug Delivery Devices market.

Global Cell and Gene Therapy Drug Delivery Devices Scope and Market Size

Cell and Gene Therapy Drug Delivery Devices market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cell and Gene Therapy Drug Delivery Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Sterile Insulin Syringe

Pre-Filled Syringe

Infusion Bags

Luxturna

Kymriah

Provenge

Zolgensma

Yescarta

Strimvelis

Amgen, Inc.

Bausch and Lomb Incorporated

Becton, Dickinson and Company

Bluebird bio, Inc.

Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)

Dendreon Pharmaceuticals LLC.

Helixmith Co., Ltd (ViroMed Co., Ltd)

Human Stem Cell Institute

Kite Pharma, Inc.

Kolon Tissue Gene, inc.

Novartis AG

Orchard Therapeutics plc.

Pfizer, Inc.

Renova Therapeutics

Spark Therapeutics, Inc.

uniQure N.V.

Vericel Corporation

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Sterile Insulin Syringe

1.2.3 Pre-Filled Syringe

1.2.4 Infusion Bags

1.3 Market by Application

1.3.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Luxturna

1.3.3 Kymriah

1.3.4 Provenge

1.3.5 Zolgensma

1.3.6 Yescarta

1.3.7 Strimvelis

1.4 Study Objectives

1.5 Years Considered

2.1 Global Cell and Gene Therapy Drug Delivery Devices Market Perspective (2017-2028)

2.2 Cell and Gene Therapy Drug Delivery Devices Growth Trends by Region

2.2.1 Cell and Gene Therapy Drug Delivery Devices Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Cell and Gene Therapy Drug Delivery Devices Historic Market Size by Region (2017-2022)

2.2.3 Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Region (2023-2028)

2.3 Cell and Gene Therapy Drug Delivery Devices Market Dynamics

2.3.1 Cell and Gene Therapy Drug Delivery Devices Industry Trends

2.3.2 Cell and Gene Therapy Drug Delivery Devices Market Drivers

2.3.3 Cell and Gene Therapy Drug Delivery Devices Market Challenges

2.3.4 Cell and Gene Therapy Drug Delivery Devices Market Restraints

3.1 Global Top Cell and Gene Therapy Drug Delivery Devices Players by Revenue

3.1.1 Global Top Cell and Gene Therapy Drug Delivery Devices Players by Revenue (2017-2022)

3.1.2 Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Players (2017-2022)

3.2 Global Cell and Gene Therapy Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Cell and Gene Therapy Drug Delivery Devices Revenue

3.4 Global Cell and Gene Therapy Drug Delivery Devices Market Concentration Ratio

3.4.1 Global Cell and Gene Therapy Drug Delivery Devices Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Drug Delivery Devices Revenue in 2021

3.5 Cell and Gene Therapy Drug Delivery Devices Key Players Head office and Area Served

3.6 Key Players Cell and Gene Therapy Drug Delivery Devices Product Solution and Service

3.7 Date of Enter into Cell and Gene Therapy Drug Delivery Devices Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Cell and Gene Therapy Drug Delivery Devices Historic Market Size by Type (2017-2022)

4.2 Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Type (2023-2028)

5.1 Global Cell and Gene Therapy Drug Delivery Devices Historic Market Size by Application (2017-2022)

5.2 Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Application (2023-2028)

6.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size (2017-2028)

6.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type

6.2.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022)

6.2.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028)

6.2.3 North America Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2017-2028)

6.3 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application

6.3.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022)

6.3.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028)

6.3.3 North America Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2017-2028)

6.4 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country

6.4.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2017-2022)

6.4.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size (2017-2028)

7.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type

7.2.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022)

7.2.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028)

7.2.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2017-2028)

7.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application

7.3.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022)

7.3.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028)

7.3.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2017-2028)

7.4 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country

7.4.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2017-2022)

7.4.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size (2017-2028)

8.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type

8.2.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2017-2028)

8.3 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application

8.3.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2017-2028)

8.4 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region

8.4.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size (2017-2028)

9.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type

9.2.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022)

9.2.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028)

9.2.3 Latin America Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2017-2028)

9.3 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application

9.3.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022)

9.3.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028)

9.3.3 Latin America Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2017-2028)

9.4 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country

9.4.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2017-2022)

9.4.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size (2017-2028)

10.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type

10.2.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2017-2028)

10.3 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application

10.3.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2017-2028)

10.4 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country

10.4.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11.1 Amgen, Inc.

11.1.1 Amgen, Inc. Company Details

11.1.2 Amgen, Inc. Business Overview

11.1.3 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction

11.1.4 Amgen, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

11.1.5 Amgen, Inc. Recent Developments

11.2 Bausch and Lomb Incorporated

11.2.1 Bausch and Lomb Incorporated Company Details

11.2.2 Bausch and Lomb Incorporated Business Overview

11.2.3 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Introduction

11.2.4 Bausch and Lomb Incorporated Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

11.2.5 Bausch and Lomb Incorporated Recent Developments

11.3 Becton, Dickinson and Company

11.3.1 Becton, Dickinson and Company Company Details

11.3.2 Becton, Dickinson and Company Business Overview

11.3.3 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Introduction

11.3.4 Becton, Dickinson and Company Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

11.3.5 Becton, Dickinson and Company Recent Developments

11.4 Bluebird bio, Inc.

11.4.1 Bluebird bio, Inc. Company Details

11.4.2 Bluebird bio, Inc. Business Overview

11.4.3 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction

11.4.4 Bluebird bio, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

11.4.5 Bluebird bio, Inc. Recent Developments

11.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)

11.5.1 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Company Details

11.5.2 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Business Overview

11.5.3 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Introduction

11.5.4 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

11.5.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Developments

11.6 Dendreon Pharmaceuticals LLC.

11.6.1 Dendreon Pharmaceuticals LLC. Company Details

11.6.2 Dendreon Pharmaceuticals LLC. Business Overview

11.6.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Introduction

11.6.4 Dendreon Pharmaceuticals LLC. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

11.6.5 Dendreon Pharmaceuticals LLC. Recent Developments

11.7 Helixmith Co., Ltd (ViroMed Co., Ltd)

11.7.1 Helixmith Co., Ltd (ViroMed Co., Ltd) Company Details

11.7.2 Helixmith Co., Ltd (ViroMed Co., Ltd) Business Overview

11.7.3 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Introduction

11.7.4 Helixmith Co., Ltd (ViroMed Co., Ltd) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

11.7.5 Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Developments

11.8 Human Stem Cell Institute

11.8.1 Human Stem Cell Institute Company Details

11.8.2 Human Stem Cell Institute Business Overview

11.8.3 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Introduction

11.8.4 Human Stem Cell Institute Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

11.8.5 Human Stem Cell Institute Recent Developments

11.9 Kite Pharma, Inc.

11.9.1 Kite Pharma, Inc. Company Details

11.9.2 Kite Pharma, Inc. Business Overview

11.9.3 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction

11.9.4 Kite Pharma, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

11.9.5 Kite Pharma, Inc. Recent Developments

11.10 Kolon Tissue Gene, inc.

11.10.1 Kolon Tissue Gene, inc. Company Details

11.10.2 Kolon Tissue Gene, inc. Business Overview

11.10.3 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Introduction

11.10.4 Kolon Tissue Gene, inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

11.10.5 Kolon Tissue Gene, inc. Recent Developments

11.11 Novartis AG

11.11.1 Novartis AG Company Details

11.11.2 Novartis AG Business Overview

11.11.3 Novartis AG Cell and Gene Therapy Drug Delivery Devices Introduction

11.11.4 Novartis AG Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

11.11.5 Novartis AG Recent Developments

11.12 Orchard Therapeutics plc.

11.12.1 Orchard Therapeutics plc. Company Details

11.12.2 Orchard Therapeutics plc. Business Overview

11.12.3 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Introduction

11.12.4 Orchard Therapeutics plc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

11.12.5 Orchard Therapeutics plc. Recent Developments

11.13 Pfizer, Inc.

11.13.1 Pfizer, Inc. Company Details

11.13.2 Pfizer, Inc. Business Overview

11.13.3 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction

11.13.4 Pfizer, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

11.13.5 Pfizer, Inc. Recent Developments

11.14 Renova Therapeutics

11.14.1 Renova Therapeutics Company Details

11.14.2 Renova Therapeutics Business Overview

11.14.3 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Introduction

11.14.4 Renova Therapeutics Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

11.14.5 Renova Therapeutics Recent Developments

11.15 Spark Therapeutics, Inc.

11.15.1 Spark Therapeutics, Inc. Company Details

11.15.2 Spark Therapeutics, Inc. Business Overview

11.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction

11.15.4 Spark Therapeutics, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

11.15.5 Spark Therapeutics, Inc. Recent Developments

11.16 uniQure N.V.

11.16.1 uniQure N.V. Company Details

11.16.2 uniQure N.V. Business Overview

11.16.3 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Introduction

11.16.4 uniQure N.V. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

11.16.5 uniQure N.V. Recent Developments

11.17 Vericel Corporation

11.17.1 Vericel Corporation Company Details

11.17.2 Vericel Corporation Business Overview

11.17.3 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Introduction

11.17.4 Vericel Corporation Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

11.17.5 Vericel Corporation Recent Developments

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

List of Tables

    Table 1. Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

    Table 2. Key Players of Sterile Insulin Syringe

    Table 3. Key Players of Pre-Filled Syringe

    Table 4. Key Players of Infusion Bags

    Table 5. Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

    Table 6. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

    Table 7. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2017-2022) & (US$ Million)

    Table 8. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Region (2017-2022)

    Table 9. Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Region (2023-2028) & (US$ Million)

    Table 10. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Region (2023-2028)

    Table 11. Cell and Gene Therapy Drug Delivery Devices Market Trends

    Table 12. Cell and Gene Therapy Drug Delivery Devices Market Drivers

    Table 13. Cell and Gene Therapy Drug Delivery Devices Market Challenges

    Table 14. Cell and Gene Therapy Drug Delivery Devices Market Restraints

    Table 15. Global Cell and Gene Therapy Drug Delivery Devices Revenue by Players (2017-2022) & (US$ Million)

    Table 16. Global Cell and Gene Therapy Drug Delivery Devices Revenue Share by Players (2017-2022)

    Table 17. Global Top Cell and Gene Therapy Drug Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Drug Delivery Devices as of 2021)

    Table 18. Ranking of Global Top Cell and Gene Therapy Drug Delivery Devices Companies by Revenue (US$ Million) in 2021

    Table 19. Global 5 Largest Players Market Share by Cell and Gene Therapy Drug Delivery Devices Revenue (CR5 and HHI) & (2017-2022)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Cell and Gene Therapy Drug Delivery Devices Product Solution and Service

    Table 22. Date of Enter into Cell and Gene Therapy Drug Delivery Devices Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022) & (US$ Million)

    Table 25. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Type (2017-2022)

    Table 26. Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Type (2023-2028) & (US$ Million)

    Table 27. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Type (2023-2028)

    Table 28. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022) & (US$ Million)

    Table 29. Global Cell and Gene Therapy Drug Delivery Devices Revenue Share by Application (2017-2022)

    Table 30. Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Application (2023-2028) & (US$ Million)

    Table 31. Global Cell and Gene Therapy Drug Delivery Devices Revenue Share by Application (2023-2028)

    Table 32. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022) & (US$ Million)

    Table 33. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028) & (US$ Million)

    Table 34. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022) & (US$ Million)

    Table 35. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028) & (US$ Million)

    Table 36. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2017-2022) & (US$ Million)

    Table 37. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2023-2028) & (US$ Million)

    Table 38. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022) & (US$ Million)

    Table 39. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028) & (US$ Million)

    Table 40. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022) & (US$ Million)

    Table 41. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028) & (US$ Million)

    Table 42. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2017-2022) & (US$ Million)

    Table 43. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2023-2028) & (US$ Million)

    Table 44. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022) & (US$ Million)

    Table 45. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028) & (US$ Million)

    Table 46. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022) & (US$ Million)

    Table 47. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028) & (US$ Million)

    Table 48. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2017-2022) & (US$ Million)

    Table 49. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2023-2028) & (US$ Million)

    Table 50. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022) & (US$ Million)

    Table 51. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028) & (US$ Million)

    Table 52. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022) & (US$ Million)

    Table 53. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028) & (US$ Million)

    Table 54. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2017-2022) & (US$ Million)

    Table 55. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2023-2028) & (US$ Million)

    Table 56. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022) & (US$ Million)

    Table 57. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028) & (US$ Million)

    Table 58. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022) & (US$ Million)

    Table 59. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028) & (US$ Million)

    Table 60. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2017-2022) & (US$ Million)

    Table 61. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2023-2028) & (US$ Million)

    Table 62. Amgen, Inc. Company Details

    Table 63. Amgen, Inc. Business Overview

    Table 64. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Product

    Table 65. Amgen, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)

    Table 66. Amgen, Inc. Recent Developments

    Table 67. Bausch and Lomb Incorporated Company Details

    Table 68. Bausch and Lomb Incorporated Business Overview

    Table 69. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Product

    Table 70. Bausch and Lomb Incorporated Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)

    Table 71. Bausch and Lomb Incorporated Recent Developments

    Table 72. Becton, Dickinson and Company Company Details

    Table 73. Becton, Dickinson and Company Business Overview

    Table 74. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Product

    Table 75. Becton, Dickinson and Company Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)

    Table 76. Becton, Dickinson and Company Recent Developments

    Table 77. Bluebird bio, Inc. Company Details

    Table 78. Bluebird bio, Inc. Business Overview

    Table 79. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Product

    Table 80. Bluebird bio, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)

    Table 81. Bluebird bio, Inc. Recent Developments

    Table 82. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Company Details

    Table 83. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Business Overview

    Table 84. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Product

    Table 85. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)

    Table 86. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Developments

    Table 87. Dendreon Pharmaceuticals LLC. Company Details

    Table 88. Dendreon Pharmaceuticals LLC. Business Overview

    Table 89. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Product

    Table 90. Dendreon Pharmaceuticals LLC. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)

    Table 91. Dendreon Pharmaceuticals LLC. Recent Developments

    Table 92. Helixmith Co., Ltd (ViroMed Co., Ltd) Company Details

    Table 93. Helixmith Co., Ltd (ViroMed Co., Ltd) Business Overview

    Table 94. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Product

    Table 95. Helixmith Co., Ltd (ViroMed Co., Ltd) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)

    Table 96. Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Developments

    Table 97. Human Stem Cell Institute Company Details

    Table 98. Human Stem Cell Institute Business Overview

    Table 99. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Product

    Table 100. Human Stem Cell Institute Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)

    Table 101. Human Stem Cell Institute Recent Developments

    Table 102. Kite Pharma, Inc. Company Details

    Table 103. Kite Pharma, Inc. Business Overview

    Table 104. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Product

    Table 105. Kite Pharma, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)

    Table 106. Kite Pharma, Inc. Recent Developments

    Table 107. Kolon Tissue Gene, inc. Company Details

    Table 108. Kolon Tissue Gene, inc. Business Overview

    Table 109. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Product

    Table 110. Kolon Tissue Gene, inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)

    Table 111. Kolon Tissue Gene, inc. Recent Developments

    Table 112. Novartis AG Company Details

    Table 113. Novartis AG Business Overview

    Table 114. Novartis AG Cell and Gene Therapy Drug Delivery Devices Product

    Table 115. Novartis AG Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)

    Table 116. Novartis AG Recent Developments

    Table 117. Orchard Therapeutics plc. Company Details

    Table 118. Orchard Therapeutics plc. Business Overview

    Table 119. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Product

    Table 120. Orchard Therapeutics plc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)

    Table 121. Orchard Therapeutics plc. Recent Developments

    Table 122. Pfizer, Inc. Company Details

    Table 123. Pfizer, Inc. Business Overview

    Table 124. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Product

    Table 125. Pfizer, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)

    Table 126. Pfizer, Inc. Recent Developments

    Table 127. Renova Therapeutics Company Details

    Table 128. Renova Therapeutics Business Overview

    Table 129. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Product

    Table 130. Renova Therapeutics Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)

    Table 131. Renova Therapeutics Recent Developments

    Table 132. Spark Therapeutics, Inc. Company Details

    Table 133. Spark Therapeutics, Inc. Business Overview

    Table 134. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Product

    Table 135. Spark Therapeutics, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)

    Table 136. Spark Therapeutics, Inc. Recent Developments

    Table 137. uniQure N.V. Company Details

    Table 138. uniQure N.V. Business Overview

    Table 139. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Product

    Table 140. uniQure N.V. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)

    Table 141. uniQure N.V. Recent Developments

    Table 142. Vericel Corporation Company Details

    Table 143. Vericel Corporation Business Overview

    Table 144. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Product

    Table 145. Vericel Corporation Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)

    Table 146. Vericel Corporation Recent Developments

    Table 147. Research Programs/Design for This Report

    Table 148. Key Data Information from Secondary Sources

    Table 149. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Type: 2021 VS 2028

    Figure 2. Sterile Insulin Syringe Features

    Figure 3. Pre-Filled Syringe Features

    Figure 4. Infusion Bags Features

    Figure 5. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Application: 2021 VS 2028

    Figure 6. Luxturna Case Studies

    Figure 7. Kymriah Case Studies

    Figure 8. Provenge Case Studies

    Figure 9. Zolgensma Case Studies

    Figure 10. Yescarta Case Studies

    Figure 11. Strimvelis Case Studies

    Figure 12. Cell and Gene Therapy Drug Delivery Devices Report Years Considered

    Figure 13. Global Cell and Gene Therapy Drug Delivery Devices Market Size (US$ Million), Year-over-Year: 2017-2028

    Figure 14. Global Cell and Gene Therapy Drug Delivery Devices Market Size, (US$ Million), 2017 VS 2021 VS 2028

    Figure 15. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Region: 2021 VS 2028

    Figure 16. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Players in 2021

    Figure 17. Global Top Cell and Gene Therapy Drug Delivery Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Drug Delivery Devices as of 2021)

    Figure 18. The Top 10 and 5 Players Market Share by Cell and Gene Therapy Drug Delivery Devices Revenue in 2021

    Figure 19. North America Cell and Gene Therapy Drug Delivery Devices Market Size YoY (2017-2028) & (US$ Million)

    Figure 20. North America Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Type (2017-2028)

    Figure 21. North America Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Application (2017-2028)

    Figure 22. North America Cell and Gene Therapy Drug Delivery Devices Market Size Share by Country (2017-2028)

    Figure 23. United States Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 24. Canada Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 25. Europe Cell and Gene Therapy Drug Delivery Devices Market Size YoY (2017-2028) & (US$ Million)

    Figure 26. Europe Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Type (2017-2028)

    Figure 27. Europe Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Application (2017-2028)

    Figure 28. Europe Cell and Gene Therapy Drug Delivery Devices Market Size Share by Country (2017-2028)

    Figure 29. Germany Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 30. France Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 31. U.K. Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 32. Italy Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 33. Russia Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 34. Nordic Countries Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 35. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size YoY (2017-2028) & (US$ Million)

    Figure 36. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Type (2017-2028)

    Figure 37. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Application (2017-2028)

    Figure 38. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Size Share by Region (2017-2028)

    Figure 39. China Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 40. Japan Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 41. South Korea Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 42. Southeast Asia Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 43. India Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 44. Australia Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

    Figure 45. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size YoY (2017-2028) & (US$ Million)

    Figure 46. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Type (2017-2028)

    Figure 47. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Application (2017-2028)

    Figure 48. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size Share by Country (2017-2028)

    Figure 49. Mexico Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 50. Brazil Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 51. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size YoY (2017-2028) & (US$ Million)

    Figure 52. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Type (2017-2028)

    Figure 53. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Application (2017-2028)

    Figure 54. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Size Share by Country (2017-2028)

    Figure 55. Turkey Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 56. Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 57. UAE Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 58. Amgen, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

    Figure 59. Bausch and Lomb Incorporated Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

    Figure 60. Becton, Dickinson and Company Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

    Figure 61. Bluebird bio, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

    Figure 62. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

    Figure 63. Dendreon Pharmaceuticals LLC. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

    Figure 64. Helixmith Co., Ltd (ViroMed Co., Ltd) Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

    Figure 65. Human Stem Cell Institute Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

    Figure 66. Kite Pharma, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

    Figure 67. Kolon Tissue Gene, inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

    Figure 68. Novartis AG Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

    Figure 69. Orchard Therapeutics plc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

    Figure 70. Pfizer, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

    Figure 71. Renova Therapeutics Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

    Figure 72. Spark Therapeutics, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

    Figure 73. uniQure N.V. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

    Figure 74. Vericel Corporation Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)

    Figure 75. Bottom-up and Top-down Approaches for This Report

    Figure 76. Data Triangulation

    Figure 77. Key Executives Interviewed